Silodosin 8 MG Oral Capsule — RxCUI 809477
RxNorm drug concept · Semantic clinical drug
RxCUI 809477
Semantic clinical drug · SCD
● Current RxNorm concept 26 FDA products
56 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI809477
Official nameSilodosin 8 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped26
Package NDCs mapped56
Reported Medicaid activity (SDUD)6,899 prescriptions · 20 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Silodosin: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Silodosin relaxes the muscle tissue around your prostate and bladder opening, which makes it easier for urine to flow. Many men notice some improvement in their urinary symptoms —...
- What exactly does silodosin do, and how quickly will I feel better?
- Not at all — what you're experiencing is called retrograde ejaculation, which means semen travels backward into the bladder rather than out during orgasm. It's actually the most co...
- I noticed I didn't ejaculate normally after starting this medication — is that dangerous?
🕸️ Concept Web — How Silodosin 8 MG Oral Capsule Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Silodosin 8 MG Oral Capsule
RxCUI 809477 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Silodosin
720825IN
-
Silodosin
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Rapaflo
809478BN
-
Rapaflo
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Silodosin Oral Capsule
809476SCDF -
Silodosin Oral Product
1159096SCDG -
Silodosin Pill
1159097SCDG -
Silodosin Oral Capsule [Rapaflo]
809480SBDF -
Rapaflo Oral Product
1177699SBDG -
Rapaflo Pill
1177700SBDG -
Oral Capsule
316965DF -
Oral Product
1151131DFG - +1 more in this family
-
Silodosin Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Silodosin 8 MG
809475SCDC -
Silodosin 8 MG Oral Capsule [Rapaflo]
809481SBD -
Silodosin 8 MG [Rapaflo]
809479SBDC
-
Silodosin 8 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Silodosin 8 MG
SCDC · 809475 -
Silodosin Oral Capsule
SCDF · 809476 -
Silodosin Oral Product
SCDG · 1159096 -
Silodosin Pill
SCDG · 1159097
Brand-Name Concepts
-
Silodosin 8 MG Oral Capsule [Rapaflo]
SBD · 809481 -
Silodosin 8 MG [Rapaflo]
SBDC · 809479 -
Silodosin Oral Capsule [Rapaflo]
SBDF · 809480 -
Rapaflo Oral Product
SBDG · 1177699 -
Rapaflo Pill
SBDG · 1177700 -
Rapaflo
BN · 809478
📦 FDA Products & Package NDCs
26 products · 56 package NDCs
56 package NDCs map to RxCUI 809477 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 27241-0144-01 | 30 CAPSULE in 1 BOTTLE (27241-144-01) | Silodosin | Ajanta Pharma USA Inc. | 2018-12-03 |
| 27241-0145-01 | 30 CAPSULE in 1 BOTTLE (27241-145-01) | Silodosin | Ajanta Pharma USA Inc. | 2018-12-03 |
| 27241-0145-03 | 90 CAPSULE in 1 BOTTLE (27241-145-03) | Silodosin | Ajanta Pharma USA Inc. | 2018-12-03 |
| 31722-0635-30 | 30 CAPSULE in 1 BOTTLE (31722-635-30) | Silodosin | Camber Pharmaceuticals, Inc. | 2020-02-14 |
| 31722-0635-31 | 30 CAPSULE in 1 BOTTLE (31722-635-31) | Silodosin | Camber Pharmaceuticals, Inc. | 2020-02-14 |
| 31722-0635-90 | 90 CAPSULE in 1 BOTTLE (31722-635-90) | Silodosin | Camber Pharmaceuticals, Inc. | 2020-02-14 |
| 31722-0635-91 | 90 CAPSULE in 1 BOTTLE (31722-635-91) | Silodosin | Camber Pharmaceuticals, Inc. | 2020-02-14 |
| 31722-0636-30 | 30 CAPSULE in 1 BOTTLE (31722-636-30) | Silodosin | Camber Pharmaceuticals, Inc. | 2020-02-14 |
| 31722-0636-31 | 30 CAPSULE in 1 BOTTLE (31722-636-31) | Silodosin | Camber Pharmaceuticals, Inc. | 2020-02-14 |
| 31722-0636-90 | 90 CAPSULE in 1 BOTTLE (31722-636-90) | Silodosin | Camber Pharmaceuticals, Inc. | 2020-02-14 |
| 31722-0636-91 | 90 CAPSULE in 1 BOTTLE (31722-636-91) | Silodosin | Camber Pharmaceuticals, Inc. | 2020-02-14 |
| 33342-0384-07 | 30 CAPSULE in 1 BOTTLE (33342-384-07) | Silodosin | Macleods Pharmaceuticals Limited | 2018-12-03 |
| 33342-0384-10 | 90 CAPSULE in 1 BOTTLE (33342-384-10) | Silodosin | Macleods Pharmaceuticals Limited | 2018-12-03 |
| 33342-0384-12 | 100 BLISTER PACK in 1 CARTON (33342-384-12) / 10 CAPSULE in... | Silodosin | Macleods Pharmaceuticals Limited | 2018-12-03 |
| 33342-0385-07 | 30 CAPSULE in 1 BOTTLE (33342-385-07) | Silodosin | Macleods Pharmaceuticals Limited | 2018-12-03 |
| 33342-0385-10 | 90 CAPSULE in 1 BOTTLE (33342-385-10) | Silodosin | Macleods Pharmaceuticals Limited | 2018-12-03 |
| 33342-0385-12 | 100 BLISTER PACK in 1 CARTON (33342-385-12) / 10 CAPSULE in... | Silodosin | Macleods Pharmaceuticals Limited | 2018-12-03 |
| 42291-0777-30 | 30 CAPSULE in 1 BOTTLE (42291-777-30) | Silodosin | AvKARE | 2022-10-04 |
| 42291-0778-90 | 90 CAPSULE in 1 BOTTLE (42291-778-90) | Silodosin | AvKARE | 2022-10-04 |
| 46708-0405-30 | 30 CAPSULE in 1 BOTTLE (46708-405-30) | Silodosin | Alembic Pharmaceuticals Limited | 2019-11-25 |
| 46708-0405-90 | 90 CAPSULE in 1 BOTTLE (46708-405-90) | Silodosin | Alembic Pharmaceuticals Limited | 2019-11-25 |
| 46708-0405-91 | 1000 CAPSULE in 1 BOTTLE (46708-405-91) | Silodosin | Alembic Pharmaceuticals Limited | 2019-11-25 |
| 46708-0406-30 | 30 CAPSULE in 1 BOTTLE (46708-406-30) | Silodosin | Alembic Pharmaceuticals Limited | 2019-11-25 |
| 46708-0406-90 | 90 CAPSULE in 1 BOTTLE (46708-406-90) | Silodosin | Alembic Pharmaceuticals Limited | 2019-11-25 |
| 46708-0406-91 | 1000 CAPSULE in 1 BOTTLE (46708-406-91) | Silodosin | Alembic Pharmaceuticals Limited | 2019-11-25 |
| 59651-0095-30 | 30 CAPSULE in 1 BOTTLE (59651-095-30) | SILODOSIN | Aurobindo Pharma Limited | 2018-12-10 |
| 59651-0095-90 | 90 CAPSULE in 1 BOTTLE (59651-095-90) | SILODOSIN | Aurobindo Pharma Limited | 2018-12-10 |
| 59651-0096-30 | 30 CAPSULE in 1 BOTTLE (59651-096-30) | SILODOSIN | Aurobindo Pharma Limited | 2018-12-10 |
| 59651-0096-90 | 90 CAPSULE in 1 BOTTLE (59651-096-90) | SILODOSIN | Aurobindo Pharma Limited | 2018-12-10 |
| 60219-1420-03 | 30 CAPSULE in 1 BOTTLE (60219-1420-3) | Silodosin | Amneal Pharmaceuticals NY LLC | 2018-12-03 |
| 60219-1420-09 | 90 CAPSULE in 1 BOTTLE (60219-1420-9) | Silodosin | Amneal Pharmaceuticals NY LLC | 2018-12-03 |
| 60219-1421-03 | 30 CAPSULE in 1 BOTTLE (60219-1421-3) | Silodosin | Amneal Pharmaceuticals NY LLC | 2018-12-03 |
| 60219-1421-09 | 90 CAPSULE in 1 BOTTLE (60219-1421-9) | Silodosin | Amneal Pharmaceuticals NY LLC | 2018-12-03 |
| 62332-0405-30 | 30 CAPSULE in 1 BOTTLE (62332-405-30) | Silodosin | Alembic Pharmaceuticals Inc. | 2019-11-25 |
| 62332-0405-90 | 90 CAPSULE in 1 BOTTLE (62332-405-90) | Silodosin | Alembic Pharmaceuticals Inc. | 2019-11-25 |
| 62332-0405-91 | 1000 CAPSULE in 1 BOTTLE (62332-405-91) | Silodosin | Alembic Pharmaceuticals Inc. | 2019-11-25 |
| 62332-0406-30 | 30 CAPSULE in 1 BOTTLE (62332-406-30) | Silodosin | Alembic Pharmaceuticals Inc. | 2019-11-25 |
| 62332-0406-90 | 90 CAPSULE in 1 BOTTLE (62332-406-90) | Silodosin | Alembic Pharmaceuticals Inc. | 2019-11-25 |
| 62332-0406-91 | 1000 CAPSULE in 1 BOTTLE (62332-406-91) | Silodosin | Alembic Pharmaceuticals Inc. | 2019-11-25 |
| 68180-0740-06 | 30 CAPSULE in 1 BOTTLE (68180-740-06) | Silodosin | Lupin Pharmaceuticals, Inc. | 2018-12-03 |
| 68180-0741-06 | 30 CAPSULE in 1 BOTTLE (68180-741-06) | Silodosin | Lupin Pharmaceuticals, Inc. | 2018-12-03 |
| 68180-0741-09 | 90 CAPSULE in 1 BOTTLE (68180-741-09) | Silodosin | Lupin Pharmaceuticals, Inc. | 2018-12-03 |
| 69238-1420-03 | 30 CAPSULE in 1 BOTTLE (69238-1420-3) | Silodosin | Amneal Pharmaceuticals NY LLC | 2018-12-03 |
| 69238-1420-09 | 90 CAPSULE in 1 BOTTLE (69238-1420-9) | Silodosin | Amneal Pharmaceuticals NY LLC | 2018-12-03 |
| 69238-1421-03 | 30 CAPSULE in 1 BOTTLE (69238-1421-3) | Silodosin | Amneal Pharmaceuticals NY LLC | 2018-12-03 |
| 69238-1421-09 | 90 CAPSULE in 1 BOTTLE (69238-1421-9) | Silodosin | Amneal Pharmaceuticals NY LLC | 2018-12-03 |
| 72162-2447-03 | 30 CAPSULE in 1 BOTTLE (72162-2447-3) | SILODOSIN | Bryant Ranch Prepack | 2024-11-14 |
| 72162-2447-09 | 90 CAPSULE in 1 BOTTLE (72162-2447-9) | SILODOSIN | Bryant Ranch Prepack | 2024-11-14 |
| 72205-0009-30 | 30 CAPSULE in 1 BOTTLE (72205-009-30) | SILODOSIN | Novadoz Pharmaceuticals LLC | 2018-12-03 |
| 72205-0010-30 | 30 CAPSULE in 1 BOTTLE (72205-010-30) | SILODOSIN | Novadoz Pharmaceuticals LLC | 2018-12-03 |
Observed labelers:
Amneal Pharmaceuticals NY LLC (8) ·
Camber Pharmaceuticals, Inc. (8) ·
Alembic Pharmaceuticals Inc. (6) ·
Alembic Pharmaceuticals Limited (6) ·
Macleods Pharmaceuticals Limited (6) ·
Aurobindo Pharma Limited (4)
· +7 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.